| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 14, 2025 | LQDA Liquidia Corp | Kaseta Michael57 | CFO And COO | Sell | 23,370 | $11.78 | $275,298.60 | -5.5% | +21.7% | +252.0% | |
| Jan 14, 2025 | LQDA Liquidia Corp | Saggar Rajeev | Chief Medical Officer | Sell | 6,249 | $11.78 | $73,613.22 | -2.3% | +21.7% | +252.0% | |
| Jan 14, 2025 | LQDA Liquidia Corp | Moomaw Scott | Chief Commercial Officer | Sell | 8,362 | $11.78 | $98,504.36 | -3.7% | +21.7% | +252.0% | |
| Jan 13, 2025 | AVDL Avadel Pharmaceuticals Plc | Ende Eric J81 | Director | Buy | 30,000 | $7.84 | $235,218.00 | +16.8% | -1.2% | +174.7% | |
| Jan 13, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Tessari Eben | Chief Operating Officer | Sell | 14,000 | $18.24 | $255,413.15 | -7.2% | +13.9% | +112.4% | |
| Jan 13, 2025 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 10,000 | $364.62 | $3,646,223.03 | -23.8% | -21.7% | +31.4% | |
| Jan 13, 2025 | AVDL Avadel Pharmaceuticals Plc | Thornton Peter J. | Director | Buy | 10,000 | $8.05 | $80,450.00 | +10.6% | -1.2% | +174.7% | |
| Jan 13, 2025 | ANIP Ani Pharmaceuticals Inc | Cook Meredith50 | Sr. VP, General Counsel &Sec. | Sell | 400 | $53.92 | $21,568.00 | -0.7% | +27.4% | +52.6% | |
| Jan 13, 2025 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 11,581 | $24.44 | $283,083.26 | -3.1% | +9.3% | +24.3% | |
| Jan 10, 2025 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 7,259 | $24.07 | $174,724.13 | -3.6% | +5.5% | +24.7% | |
| Jan 10, 2025 | COLL Collegium Pharmaceutical, Inc | Kuhlmann Shirley R.49 | EVP And General Counsel | Sell | 27,500 | $33.04 | $908,627.77 | -10.1% | -25.0% | +38.4% | |
| Jan 10, 2025 | UTHR United Therapeutics Corp | Patusky Christopher50 | Director | Sell | 5,000 | $361.61 | $1,808,071.86 | -21.1% | -23.6% | +32.4% | |
| Jan 8, 2025 | LFCR Lifecore Biomedical, Inc. \de\ | Josephs Paul | Chief Executive Officer | Buy | 17,000 | $5.74 | $97,580.00 | +3.1% | -10.2% | +34.0% | |
| Jan 8, 2025 | ETST Earth Science Tech, Inc. | Cazeau Jeff P. H. | Independent Director | Buy | 72,555 | $0.14 | $10,518.97 | +9.8% | - | - | |
| Jan 8, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Patel Gautam | Director | Sell | 62,590 | $8.01 | $501,345.90 | -3.1% | -13.3% | +63.8% | |
| Jan 7, 2025 | ETST Earth Science Tech, Inc. | Cazeau Jeff P. H. | Independent Director | Buy | 79,200 | $0.12 | $9,504.00 | +46.6% | - | - | |
| Jan 6, 2025 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 10,000 | $355.15 | $3,551,517.17 | -39.9% | -17.9% | +41.5% | |
| Jan 6, 2025 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 268,932 | $27.75 | $7,463,195.04 | -42.1% | +3.2% | +31.8% | |
| Jan 6, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Klee Justin B.60 | Co-chief Executive Officer | Sell | 7,471 | $4.04 | $30,201.52 | -0.2% | -11.7% | +190.3% | |
| Jan 6, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Cohen Joshua B60 | Co-chief Executive Officer | Sell | 7,471 | $4.05 | $30,232.15 | -0.2% | -11.7% | +190.3% | |
| Jan 6, 2025 | PCRX Pacira Biosciences, Inc. | Slonin Jonathan72 | Chief Medical Officer | Sell | 879 | $18.40 | $16,173.60 | -0.9% | +23.0% | +35.9% | |
| Jan 3, 2025 | BSPK Bespoke Extracts, Inc. | Feinsod Michael | CEO | Buy | 13,000 | $0.11 | $1,385.00 | +0.3% | - | - | |
| Jan 2, 2025 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 11,581 | $24.68 | $285,783.63 | -3.0% | +23.9% | +32.6% | |
| Jan 2, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Patel Gautam | Director | Sell | 17,410 | $8.01 | $139,454.10 | -0.8% | +5.3% | +63.1% | |
| Jan 2, 2025 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 2,055 | $24.62 | $50,594.10 | -1.1% | +23.9% | +32.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.